The Institute of Cancer Research
@icr.ac.uk
The ICR is making the discoveries that defeat cancer.
We're a top UK academic research centre, a postgrad college, and a charity.
📍 London (Chelsea and Sutton)
https://www.icr.ac.uk/
We're a top UK academic research centre, a postgrad college, and a charity.
📍 London (Chelsea and Sutton)
https://www.icr.ac.uk/
We’re incredibly delighted to have Dr Harrison join our community as we continue to strengthen and shape the future of cancer research.
Learn more about Dr Harrison and her role on our Board of Trustees⤵️
Learn more about Dr Harrison and her role on our Board of Trustees⤵️
ICR appoints global business leader as new Trustee
ICR appoints global business leader as new Trustee
www.icr.ac.uk
February 6, 2026 at 11:34 AM
We’re incredibly delighted to have Dr Harrison join our community as we continue to strengthen and shape the future of cancer research.
Learn more about Dr Harrison and her role on our Board of Trustees⤵️
Learn more about Dr Harrison and her role on our Board of Trustees⤵️
✨ We're delighted to welcome Dr Michelle Harrison to our Board of Trustees.
Dr Harrison brings decades of invaluable experience in global policy, public affairs, and branding. She currently serves at the President and was founding CEO of the @veriangroup.com
Dr Harrison brings decades of invaluable experience in global policy, public affairs, and branding. She currently serves at the President and was founding CEO of the @veriangroup.com
February 6, 2026 at 11:34 AM
✨ We're delighted to welcome Dr Michelle Harrison to our Board of Trustees.
Dr Harrison brings decades of invaluable experience in global policy, public affairs, and branding. She currently serves at the President and was founding CEO of the @veriangroup.com
Dr Harrison brings decades of invaluable experience in global policy, public affairs, and branding. She currently serves at the President and was founding CEO of the @veriangroup.com
Led by Aviva Capital Partners and Socius, the new development will bring one million square feet of brand-new labs and research space to The London Cancer Hub, which is already home to the ICR, The Royal Marsden NHS Foundation Trust, and the Innovation Gateway.
Find out more ⬇️
Find out more ⬇️
ICR welcomes approval of plans for major life-sciences district The London Cancer Hub
ICR welcomes approval of plans for major life-sciences district The London Cancer Hub
www.icr.ac.uk
February 5, 2026 at 11:17 AM
Led by Aviva Capital Partners and Socius, the new development will bring one million square feet of brand-new labs and research space to The London Cancer Hub, which is already home to the ICR, The Royal Marsden NHS Foundation Trust, and the Innovation Gateway.
Find out more ⬇️
Find out more ⬇️
🚨🎉We’re delighted to welcome the approval of the exciting plans to create a major new district for oncology and life sciences companies in Sutton, south London.
February 5, 2026 at 11:17 AM
🚨🎉We’re delighted to welcome the approval of the exciting plans to create a major new district for oncology and life sciences companies in Sutton, south London.
Today, on #WorldCancerDay, the Government have published their National Cancer Plan for England.
Read our Chief Executive, Professor @helink.bsky.social view from the ICR and find the full National Cancer plan ⤵️
www.icr.ac.uk/about-us/icr...
Read our Chief Executive, Professor @helink.bsky.social view from the ICR and find the full National Cancer plan ⤵️
www.icr.ac.uk/about-us/icr...
February 4, 2026 at 3:31 PM
Today, on #WorldCancerDay, the Government have published their National Cancer Plan for England.
Read our Chief Executive, Professor @helink.bsky.social view from the ICR and find the full National Cancer plan ⤵️
www.icr.ac.uk/about-us/icr...
Read our Chief Executive, Professor @helink.bsky.social view from the ICR and find the full National Cancer plan ⤵️
www.icr.ac.uk/about-us/icr...
Read from from us here ⬇️
ICR-led project awarded major funding to improve safety, transparency and public confidence around AI tools used in healthcare
ICR-led project awarded major funding to improve safety, transparency and public confidence around AI tools used in healthcare
www.icr.ac.uk
January 28, 2026 at 4:44 PM
Read from from us here ⬇️
The insights and prototypes developed over the next 12 months will contribute to shaping national data research infrastructure and strengthening the UK’s leadership in responsible, secure health data science.
January 28, 2026 at 4:44 PM
The insights and prototypes developed over the next 12 months will contribute to shaping national data research infrastructure and strengthening the UK’s leadership in responsible, secure health data science.
A major focus of FIREDANSE is building public trust. Through meaningful engagement, the project will help people understand how sensitive data are protected while enabling important research across institutions.
January 28, 2026 at 4:44 PM
A major focus of FIREDANSE is building public trust. Through meaningful engagement, the project will help people understand how sensitive data are protected while enabling important research across institutions.
The project also includes upgraded tools to support expert clinical review, helping ensure that AI systems remain reliable, well‑validated and closely overseen by specialists throughout development and deployment.
January 28, 2026 at 4:44 PM
The project also includes upgraded tools to support expert clinical review, helping ensure that AI systems remain reliable, well‑validated and closely overseen by specialists throughout development and deployment.
By connecting datasets held in two major Trusted Research Environments, FIREDANSE will enable researchers to train stronger, more accurate AI models for cancer diagnosis and treatment.
January 28, 2026 at 4:44 PM
By connecting datasets held in two major Trusted Research Environments, FIREDANSE will enable researchers to train stronger, more accurate AI models for cancer diagnosis and treatment.
Exciting news! 🚨
Along with The Royal Marsden and @imperialcollegeldn.bsky.social, we have secured major new funding through DARE UK to launch FIREDANSE – an innovative project designed to improve the safety, transparency and public confidence surrounding the use of #AI in healthcare.
🧵⤵️
Along with The Royal Marsden and @imperialcollegeldn.bsky.social, we have secured major new funding through DARE UK to launch FIREDANSE – an innovative project designed to improve the safety, transparency and public confidence surrounding the use of #AI in healthcare.
🧵⤵️
January 28, 2026 at 4:44 PM
Exciting news! 🚨
Along with The Royal Marsden and @imperialcollegeldn.bsky.social, we have secured major new funding through DARE UK to launch FIREDANSE – an innovative project designed to improve the safety, transparency and public confidence surrounding the use of #AI in healthcare.
🧵⤵️
Along with The Royal Marsden and @imperialcollegeldn.bsky.social, we have secured major new funding through DARE UK to launch FIREDANSE – an innovative project designed to improve the safety, transparency and public confidence surrounding the use of #AI in healthcare.
🧵⤵️
Read more from us here ⤵️
Study sets out clear recommendations for patient-reported outcomes in early cancer drug trials
Study sets out clear recommendations for patient-reported outcomes in early cancer drug trials
www.icr.ac.uk
January 27, 2026 at 3:28 PM
Read more from us here ⤵️
This works supports higher quality research while ensuring that patient experiences play a meaningful role into informed treatment decisions around dosing and cancer drug development.
January 27, 2026 at 3:28 PM
This works supports higher quality research while ensuring that patient experiences play a meaningful role into informed treatment decisions around dosing and cancer drug development.
Supported through a PhD studentship awarded to
@mle-alger.bsky.social in the Clinical Trials and Statistic Unit @icr-ctsu.bsky.social our researchers led an international effort to incorporate patient-reported outcomes into cancer drug trials to identify safe and effective doses of new treatments.
@mle-alger.bsky.social in the Clinical Trials and Statistic Unit @icr-ctsu.bsky.social our researchers led an international effort to incorporate patient-reported outcomes into cancer drug trials to identify safe and effective doses of new treatments.
January 27, 2026 at 3:28 PM
Supported through a PhD studentship awarded to
@mle-alger.bsky.social in the Clinical Trials and Statistic Unit @icr-ctsu.bsky.social our researchers led an international effort to incorporate patient-reported outcomes into cancer drug trials to identify safe and effective doses of new treatments.
@mle-alger.bsky.social in the Clinical Trials and Statistic Unit @icr-ctsu.bsky.social our researchers led an international effort to incorporate patient-reported outcomes into cancer drug trials to identify safe and effective doses of new treatments.
New research introduces the first practical guidance on how patients’ own assessments of how tolerable they find treatments (patient-reported outcomes) can be used more effectively to inform and design early-stage cancer drug trials.
A thread 🧵⬇️
A thread 🧵⬇️
January 27, 2026 at 3:28 PM
New research introduces the first practical guidance on how patients’ own assessments of how tolerable they find treatments (patient-reported outcomes) can be used more effectively to inform and design early-stage cancer drug trials.
A thread 🧵⬇️
A thread 🧵⬇️
Read more from us ⤵️
ICR welcomes NICE recommendation of talazoparib for advanced prostate cancer
ICR welcomes NICE recommendation of talazoparib for advanced prostate cancer
www.icr.ac.uk
January 26, 2026 at 1:43 PM
Read more from us ⤵️
🚨 Talazoparib has been recommended by @nicecomms.bsky.social for the treatment of advanced #ProstateCancer.
The drug now joins olaparib as one of the first genetically targeted treatments for prostate cancer. As a targeted therapy, it is a much kinder option for patients than chemotherapy.
The drug now joins olaparib as one of the first genetically targeted treatments for prostate cancer. As a targeted therapy, it is a much kinder option for patients than chemotherapy.
January 26, 2026 at 1:43 PM
🚨 Talazoparib has been recommended by @nicecomms.bsky.social for the treatment of advanced #ProstateCancer.
The drug now joins olaparib as one of the first genetically targeted treatments for prostate cancer. As a targeted therapy, it is a much kinder option for patients than chemotherapy.
The drug now joins olaparib as one of the first genetically targeted treatments for prostate cancer. As a targeted therapy, it is a much kinder option for patients than chemotherapy.
Group Leader, Cancer Stem Cell Biology:
We’re seeking an experienced Group Leader to play a pivotal role in advancing our pioneering cancer research. You will help drive forward our strategic focus on understanding cancer with a particular emphasis on the role of cancer stem cells.
Apply ⬇️
We’re seeking an experienced Group Leader to play a pivotal role in advancing our pioneering cancer research. You will help drive forward our strategic focus on understanding cancer with a particular emphasis on the role of cancer stem cells.
Apply ⬇️
Group Leader in Cancer Stem Cell Biology in Sutton | The Institute of Cancer Research
View details and apply for this Group Leader in Cancer Stem Cell Biology vacancy in Sutton.
Salary: For Career Faculty, a competitive salary will be determined by the CEO of the ICR.
...
jobs.icr.ac.uk
January 20, 2026 at 2:36 PM
Group Leader, Cancer Stem Cell Biology:
We’re seeking an experienced Group Leader to play a pivotal role in advancing our pioneering cancer research. You will help drive forward our strategic focus on understanding cancer with a particular emphasis on the role of cancer stem cells.
Apply ⬇️
We’re seeking an experienced Group Leader to play a pivotal role in advancing our pioneering cancer research. You will help drive forward our strategic focus on understanding cancer with a particular emphasis on the role of cancer stem cells.
Apply ⬇️
Group Leader, 𝘐𝘯 𝘝𝘪𝘷𝘰 Cancer Modelling:
We're looking for an exceptional individual to generate and employ state-of-the-art genetic and humanised mouse models of cancer to tackle fundamental and translational questions in haemato-oncology and/or solid tumour oncology.
Apply ⬇️
We're looking for an exceptional individual to generate and employ state-of-the-art genetic and humanised mouse models of cancer to tackle fundamental and translational questions in haemato-oncology and/or solid tumour oncology.
Apply ⬇️
Group Leader in In Vivo Cancer Modelling in Sutton | The Institute of Cancer Research
View details and apply for this Group Leader in In Vivo Cancer Modelling vacancy in Sutton.
Tenure:
We welcome applications at both the Career Development Faculty and Career Faculty...
jobs.icr.ac.uk
January 20, 2026 at 2:36 PM
Group Leader, 𝘐𝘯 𝘝𝘪𝘷𝘰 Cancer Modelling:
We're looking for an exceptional individual to generate and employ state-of-the-art genetic and humanised mouse models of cancer to tackle fundamental and translational questions in haemato-oncology and/or solid tumour oncology.
Apply ⬇️
We're looking for an exceptional individual to generate and employ state-of-the-art genetic and humanised mouse models of cancer to tackle fundamental and translational questions in haemato-oncology and/or solid tumour oncology.
Apply ⬇️
Read more about our #BreastCancer blood test research, funded by @breastcancernow.bsky.social and @nihr.bsky.social, in @andrewgregory.com's article in @theguardian.com ⤵️
www.theguardian.com/science/2026...
www.theguardian.com/science/2026...
Simple blood test can predict which breast cancer treatment will work best, study finds
Exclusive: DNA test means patients could be offered most effective treatment first, boosting their chances of beating the disease
www.theguardian.com
January 18, 2026 at 5:24 PM
Read more about our #BreastCancer blood test research, funded by @breastcancernow.bsky.social and @nihr.bsky.social, in @andrewgregory.com's article in @theguardian.com ⤵️
www.theguardian.com/science/2026...
www.theguardian.com/science/2026...
The blood test can tell doctors how likely a patient is to respond to a specific treatment, meaning patients could be offered alternative options, and avoid treatments that won’t help them, boosting their chances of beating the disease.
Read more ⤵️
www.icr.ac.uk/about-us/icr...
Read more ⤵️
www.icr.ac.uk/about-us/icr...
Breast cancer blood test can predict treatment response
Breast cancer blood test can predict treatment response
www.icr.ac.uk
January 18, 2026 at 5:24 PM
The blood test can tell doctors how likely a patient is to respond to a specific treatment, meaning patients could be offered alternative options, and avoid treatments that won’t help them, boosting their chances of beating the disease.
Read more ⤵️
www.icr.ac.uk/about-us/icr...
Read more ⤵️
www.icr.ac.uk/about-us/icr...
These levels were strongly associated with patients’ outcomes – including how long it took for a cancer to grow, and how well the cancer was responding to treatment.
January 18, 2026 at 5:24 PM
These levels were strongly associated with patients’ outcomes – including how long it took for a cancer to grow, and how well the cancer was responding to treatment.
ICR researchers, based in the @breastcancernow.bsky.social Toby Robins Research Centre, have shown that their blood test can detect levels of tiny amounts of cancer DNA in the blood – at the start of treatment, and four weeks into the treatment.
January 18, 2026 at 5:24 PM
ICR researchers, based in the @breastcancernow.bsky.social Toby Robins Research Centre, have shown that their blood test can detect levels of tiny amounts of cancer DNA in the blood – at the start of treatment, and four weeks into the treatment.
📰NEWS: A simple blood test can predict how well patients with #BreastCancer will respond to targeted therapies – before treatment begins.
Read more in our 🧵 ⤵️
Read more in our 🧵 ⤵️
January 18, 2026 at 5:24 PM
📰NEWS: A simple blood test can predict how well patients with #BreastCancer will respond to targeted therapies – before treatment begins.
Read more in our 🧵 ⤵️
Read more in our 🧵 ⤵️